Dr Hatcher expresses concern about the use of the abbreviation 'PWE' rather than the phrase 'person with epilepsy', which he considers an offensive and stigmatising practice. As a researcher on stigma, I have some sympathy with Dr Hatcher's position -to be abbreviated is a state unlikely to be welcomed by any of us, whether we have epilepsy or any other condition of human being. Dr Hatcher makes the point that abbreviations and acronyms are common parlance in the present day -and certainly, I have been present in many meetings where to any 'outsider' the language, steeped in such devices, must seem quite confounding. 3 not at all. The habit of abbreviating the terms, 'person with epilepsy' or 'people with epilepsy' has, I would suggest, been adopted by academic journals for the purposes of nothing more aggressive than the desire to save print space -the use of such abbreviations seeming to be a pragmatic response to the exigencies of journal word counts and the often highly restricted limitations on space imposed by publishers. In the case of Schachter's article, for example, 34 words would have become over 100 in an unabbreviated version. In my own recent paper, 4 I and my co-authors used the abbreviation 'PWE' 14 times; along with the abbreviations, QOL (for 'quality of life') 137 times and HRQOL (for 'health-related quality of life') 19 times and WHO (World Health Organisation) four times -a total saving of around 400 words (i.e. 5% of the length) across an article of just over 8000 words. Though these illustrations of the habit of abbreviation are in no way a defence of the practice Dr Hatcher abhors, they are offered as a simple explanation for its use. However, it must be also acknowledged that in the brave new world of on-line publishing, word limits are set to become a thing of the past. The American Psychological Association 5 suggests that abbreviations can help to maximise clarity in scientific writing, but also advises that they be used sparingly. All that said, Dr Hatcher is, I think, to be thanked for challenging what has become publication custom and practice. Though Tannenbaum wrote about labelling theory in the context of criminology, sociologists have also devoted much study time to labelling theory as it applies to conditions of ill-health such as mental illness, obesity and, of course, epilepsy. 6 In a real-life context, the disability movement has fought long and hard to establish an agenda of equality and the rights of people labelled as 'disabled' 7 who, it has been argued, are constructed as 'largely invisible others'. 8 The demise of the label 'epileptic' -still a common descriptor when I embarked on my own academic career -has been an important part of efforts by campaigning groups to address the issue of the stigma of epilepsy, which has for so long plagued the lives of those so affected. Authors need to be reminded that the use of academic lingo including terms such as 'PWE' may be another way in which people with epilepsy are rendered, albeit unintentionally, as largely invisible.
What is needed here, it seems to me, is an informed debate amongst all parties with a vested interest (people with epilepsy, clinicians, academics, journal editors -the epilepsy community in its broadest sense) about the terminology we should adopt. People with epilepsy could then express their preferences about how they should be referred to in this context specifically as well as more widely. Some years ago, I and my colleagues canvassed opinion about how to refer to seizures in questionnaires focusing on quality of life issues. The outcome determined use of terminology in our future studies. There are methodologies well-suited to this kind of consensus seeking exercise 9 and studies could be supported online by the epilepsy charities as part of their campaigning agenda.
